Co-Authors
This is a "connection" page, showing publications co-authored by Gennaro Ciliberto and Francesco Marchesi.
Connection Strength
0.119
-
Lower response to BNT162b2 vaccine in patients with myelofibrosis compared to polycythemia vera and essential thrombocythemia. J Hematol Oncol. 2021 07 29; 14(1):119.
Score: 0.060
-
Fifth-week immunogenicity and safety of anti-SARS-CoV-2 BNT162b2 vaccine in patients with multiple myeloma and myeloproliferative malignancies on active treatment: preliminary data from a single institution. J Hematol Oncol. 2021 05 17; 14(1):81.
Score: 0.059